VDVIX
Price
$14.93
Change
+$0.15 (+1.01%)
Updated
Sep 11 closing price
Net Assets
242.06B
VTSNX
Price
$157.29
Change
+$1.52 (+0.98%)
Updated
Sep 11 closing price
Net Assets
525.66B
Interact to see
Advertisement

VDVIX vs VTSNX

Header iconVDVIX vs VTSNX Comparison
Open Charts VDVIX vs VTSNXBanner chart's image
Vanguard Developed Markets Index I
Price$14.93
Change+$0.15 (+1.01%)
VolumeN/A
Net Assets242.06B
Vanguard Total Intl Stock Index I
Price$157.29
Change+$1.52 (+0.98%)
VolumeN/A
Net Assets525.66B
VDVIX vs VTSNX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VDVIX vs. VTSNX commentary
Sep 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VDVIX is a Buy and VTSNX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 526B vs. VDVIX (242B). VTSNX pays higher dividends than VDVIX: VTSNX (2.73) vs VDVIX (2.52). VDVIX was incepted earlier than VTSNX: VDVIX (12 years) vs VTSNX (15 years). VDVIX (0.16) is less costly to investors than VTSNX (0.06). VDVIX (3.00) and VTSNX (3.00) have comparable annual turnover. VDVIX has a lower initial minimum investment than VTSNX: VDVIX (0) vs VTSNX (5000000). VTSNX annual gain was more profitable for investors over the last year : 18.42 vs. VDVIX (17.20). VDVIX return over 5 years is better than : 46.06 vs. VTSNX (42.47).
VDVIXVTSNXVDVIX / VTSNX
Total Expense Ratio0.160.06267%
Annual Report Gross Expense Ratio0.160.06267%
Fund Existence12 years15 years-
Gain YTD24.50223.286105%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets242B526B46%
Annual Yield % from dividends2.522.7392%
Returns for 1 year17.2018.4293%
Returns for 3 years45.5342.97106%
Returns for 5 years46.0642.47108%
Returns for 10 years70.6272.1898%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CERO5.500.51
+10.33%
CERO Therapeutics Holdings Inc
NFBK11.980.34
+2.92%
Northfield Bancorp
JEF67.181.60
+2.44%
Jefferies Financial Group
FBNC55.230.49
+0.90%
First Bancorp
BDMD2.500.01
+0.40%
Baird Medical Investment Holdings Ltd